Navigation Links
Glemser Announces New Labeling Solution: SPL for DCM Addresses New SPL Release 4 Requirements
Date:10/6/2008

Glemser Technologies, a Bethlehem, PA based pharmaceutical software and services company, today announced SPL for DCM, a new out-of-the-box labeling solution based on Documentum's Documentum Compliance Manager (DCM) application. SPL for DCM provides a complete labeling content management solution and addresses the SPL Release 4 submission standard mandated by the FDA, and represents the latest addition to Glemser's family of pharmaceutical labeling solutions.

Bethlehem, PA (PRWEB) October 6, 2008 -- Glemser Technologies, a Bethlehem, PA based pharmaceutical software and services company, today announced SPL for DCM, a new out-of-the-box labeling solution based on Documentum's Documentum Compliance Manager (DCM) application. SPL for DCM provides a complete labeling content management solution and addresses the SPL Release 4 submission standard mandated by the FDA, and represents the latest addition to Glemser's family of pharmaceutical labeling solutions.

Glemser's SPL for DCM solution is built on the Documentum 6.5 platform, and is implemented as a set of feature extensions and configurations of Documentum's DCM application. This architecture provides the benefit of DCM's proven, user-friendly application environment while delivering a complete set of features focused on managing package inserts and related labeling documentation. SPL for DCM also includes the ability to generate a complete SPL Release 4 submission file from content managed in the DCM environment. Like Glemser's other labeling solutions such as xmLabeling, the system also seamlessly integrates with either the PTC/Arbortext Epic or In.vision XML editors for creation and editing of content, and includes is pre-configured with the required document types and workflows to address labeling content processes.

According to Andrew Glemser, Chief Technology Officer of Glemser Technologies, "The exciting thing about SPL® for DCM is that it provides our clients the opportunity to implement a complete labeling and SPL Release 4 solution within the DCM application environment. DCM already provides a set of capabilities to address FDA regulatory requirements for controlled content, and SPL for DCM adds additional functionality directly targeted at the management of labeling content. The result is a seamless application environment that extends the range of the DCM platform."
SPL for DCM is scheduled for general release in December of this year.

About Glemser Technologies
Founded in 1987, Glemser designs and implements XML and content management solutions for life sciences companies. Glemser's solutions include xmLabeling, the leading content management solution for pharmaceutical labeling, which includes support for SPL and PIM. Glemser solutions allow pharmaceutical, consumer healthcare, medical device, and biotechnology companies to effectively address their research and development, regulatory affairs, manufacturing, quality assurance, and sales and marketing content management needs. For more information about Glemser Technologies and our other XML-based and SharePoint life sciences solutions, please visit us at www.glemser.com or contact us directly at inquiry@glemser.com.

Public Relations Contact:
Margaret Mottolo
Margaret.Mottolo @ glemser.com
781-995-0238

###

Read the full story at http://www.prweb.com/releases/2008/10/prweb1417584.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
2. Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners
3. Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics
4. SyntheMed Announces New Management Appointments
5. Alba Therapeutics Corporation Announces Promotions
6. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
7. 23andMe Announces Breast Cancer Initiative
8. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
9. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2008 Results
10. Synthetech Announces New Director of Manufacturing
11. Micromet Announces Definitive Agreement for $40 Million Private Equity Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... , Jan. 20, 2017 Aratana Therapeutics, ... company focused on the licensing, development and commercialization of ... Pharm,s Best Company in North America ... the award based on the FDA approval ... (grapiprant tablets), ENTYCE ® (capromorelin oral solution) and ...
(Date:1/20/2017)... ... , ... The two newest companies to join the University City Science Center’s ... from The Wistar Institute, and Sanguis, launched by a trio of students from the ... Vironika is developing a treatment for a chronic viral infection and its associated diseases, ...
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
Breaking Biology Technology:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL ... desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar ... 2017, con múltiples sitios previstos a lo largo de Europa y ... MSC-1 es ... inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ...
(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):